Immunotherapy Today

Immunotherapy News From Around The World

< Immunotherapy Today home

Author: btwatson

  • Immunotherapy Combos May Mark Future of Gastric Cancer Care – OncLive
    Immunotherapy Combos May Mark Future of Gastric Cancer Care – OncLive
  • Parker Institute to Share Pancreatic Cancer Trial Results, Microbiome and Immunotherapy Research, and New CAR-T Approaches at AACR 2019 – BioSpace
    Parker Institute to Share Pancreatic Cancer Trial Results, Microbiome and Immunotherapy Research, and New CAR-T Approaches at AACR 2019 – BioSpace
  • FDA OKs First Immunotherapy Regimen for Extensive Small Cell Lung Cancer – Specialty Pharmacy Times
    FDA OKs First Immunotherapy Regimen for Extensive Small Cell Lung Cancer – Specialty Pharmacy Times
  • Immunotherapy breast cancer treatment offering hope – WHAS11.com
  • FDA approves breast cancer immunotherapy treatment – Wink News
  • Parker Institute to Share Pancreatic Cancer Trial Results, Microbiome and Immunotherapy Research, and New CAR-T Approaches at AACR 2019 – PRNewswire
    Parker Institute to Share Pancreatic Cancer Trial Results, Microbiome and Immunotherapy Research, and New CAR-T Approaches at AACR 2019 – PRNewswire
  • Immunotherapy 'Safe and Efficacious' for Advanced-Stage Cancer Treatment for Patients With HIV – Curetoday.com
    Immunotherapy 'Safe and Efficacious' for Advanced-Stage Cancer Treatment for Patients With HIV – Curetoday.com
  • FDA to Evaluate Immunotherapy for Peanut Allergy – Specialty Pharmacy Times
    FDA to Evaluate Immunotherapy for Peanut Allergy – Specialty Pharmacy Times
  • Experts Remain Hopeful About Immunotherapy in HCC – OncLive
    Experts Remain Hopeful About Immunotherapy in HCC – OncLive
  • Phase 2 Trial of OncBioMune's Immunotherapy Cancer Vaccine ProscaVax for Prostate Cancer Patients in Active Surveillance Now Open for Enrollment – GlobeNewswire
< Newer Entries   |   Older Entries >
Copyright 2018 ImmunoTherapyToday.com